Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mira Ganslmeier

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 14, 2020
Persistent inhibitor in acquired haemophilia A: A case for emicizumab?Mira Ganslmeier, Isabell Pekrul, Daniel Alexander Heinrich, et al.
Thrombosis and Haemostasis|May 3, 2026
Assessment of Commutability in Factor VIII Activity Testing Using Fresh Human Plasma SamplesLaura Vierbaum, Michael Weigand, Mira Ganslmeier, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 14, 2020
Persistent inhibitor in acquired haemophilia A: A case for emicizumab?Mira Ganslmeier, Isabell Pekrul, Daniel Alexander Heinrich, et al.
Thrombosis and Haemostasis|May 3, 2026
Assessment of Commutability in Factor VIII Activity Testing Using Fresh Human Plasma SamplesLaura Vierbaum, Michael Weigand, Mira Ganslmeier, et al.
Pageof 1